Osteoporosis Treatment Industry Forecast to Hit $17.73 Billion by 2029 With a Strong 5% CAGR

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Osteoporosis Treatment Market?

The osteoporosis treatment market has experienced consistent expansion in its size over recent years. This market is projected to expand from $13.96 billion in 2024 to $14.57 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 4.4%. Key factors contributing to this historical growth include an increasingly older population, advancements in hormone replacement therapies, wider adoption of calcium and vitamin D supplementation, the availability of more sophisticated diagnostic tools, and the increasing integration of digital health solutions.

The osteoporosis treatment market size is expected to show significant expansion in the coming years. It is projected to reach $17.73 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.0%. This growth during the forecast period can be attributed to factors such as an increase in sedentary lifestyles, the growing prevalence of secondary osteoporosis, the emergence of virtual bone fracture clinics, the application of gene therapy for osteoporosis, and a heightened focus on men’s bone health. Prominent trends anticipated in this period include advancements in biologics, the integration of artificial intelligence, the use of blockchain technology in bone health records, and the incorporation of machine learning.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12166&type=smp

Which Drivers Are Shaping The Osteoporosis Treatment Industry’s Market Share?

The expanding occurrence and rise of osteoporosis are anticipated to boost the osteoporosis treatment market’s future growth. This bone condition, osteoporosis, emerges when there are alterations in bone strength and composition or a decrease in bone mass and mineral density. The majority of medications for osteoporosis operate by reducing the pace of bone deterioration. Concurrently, hormone-based therapies, including estrogen, can assist in preserving bone density, particularly if administered soon after menopause. As an illustration, Amgen, a US-based biopharmaceutical firm, reported in May 2022 that osteoporotic fractures are projected to rise annually by 68% to 3.2 million by the year 2040. Additionally, the National Library of Medicine, a US-based national resource for health professionals, indicated in April 2022 that approximately 549,000 new fragility fractures are recorded yearly in the UK, with men accounting for one-third of these instances, as of 2022. This figure is expected to climb by 19.6% by 2030, driven by the aging demographic. Consequently, the growing prevalence and incidence of osteoporosis are fueling the expansion of the osteoporosis treatment market.

What Are The Major Segment Types Covered In The Osteoporosis Treatment Market?

The osteoporosis treatmentmarket covered in this report is segmented –

1) By Drug Type: Bisphosphonates; Calcitonin; Hormone Therapy; Selective Estrogen Receptor Modulators (SERMs); Parathyroid Hormone-Related Protein (PTHrP) Analog; Rank Ligand (RANKL) Inhibitor

2) By Route Of Administration: Oral; Injectable; Other Routes

3) By Distribution Channel: Hospitals; Retail Pharmacies And Stores; Online Pharmacies

Subsegments:

1) By Bisphosphonates: Alendronate; Risedronate; Ibandronate; Zoledronic Acid

2) By Calcitonin: Salmon Calcitonin; Synthetic Calcitonin Formulations

3) By Hormone Therapy: Estrogen Replacement Therapy; Combination Hormone Therapy (Estrogen And Progesterone)

4) By Selective Estrogen Receptor Modulators (SERMs); Raloxifene; Bazedoxifene

5) By Parathyroid Hormone-Related Protein (PTHrP) Analog: PTH Analog (Teriparatide); Other PTHrP Analogues

6) By Rank Ligand (RANKL) Inhibito: Denosumab

Which Key Trends Are Expected To Influence The Osteoporosis Treatment Market In The Coming Years?

Prominent companies in the osteoporosis treatment market are concentrating on creating advanced injectable solutions for osteoporosis to secure their market presence. Injectable osteoporosis treatments are medications administered by injection to prevent bone loss and mitigate the risk of fractures for individuals with osteoporosis. These solutions offer a direct means to improve bone density and strengthen skeletal health. For example, in November 2023, Apotex Corp., a pharmaceutical corporation based in Canada, introduced Teriparatide Injection. This product is a pre-filled pen designated for single-patient use in addressing osteoporosis. It features a concentration of 250 mcg/mL and provides 28 daily doses of 20 mcg per pen. The objective of this product is to improve access to affordable treatment for approximately 10 million Americans affected by osteoporosis. Its development highlights Apotex’s commitment to producing complex generic medications, guaranteeing that patients receive high-quality care.

Which Key Players Are Driving Competition In The Osteoporosis Treatment Market?

Major companies operating in the osteoporosis treatment market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck and Co Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline Pharmaceutical Ltd., Takeda Pharmaceutical Company, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Corporation, AstraZeneca Plc., Viatris Inc., Teva Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Ltd, Dr. Reddy’s Laboratories, Gedeon Richter Plc., Celltrion Inc., Luye Pharma Group, Ligand Pharmaceuticals Incorporated, Radius Health Inc., Haoma Medica Ltd., EffRx Pharmaceuticals SA

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report

How Does The Osteoporosis Treatment Market Perform Across Key Geographic Regions?

North America was the largest region in the osteoporosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Osteoporosis Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12166&type=smp

Browse Through More Reports Similar to the Global Osteoporosis Treatment Market 2025, By The Business Research Company

Warehouse Robotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/warehouse-robotics-global-market-report

Electric Truck Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electric-truck-global-market-report

Refrigerated Goods Trucking Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/refrigerated-goods-trucking-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795